Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).
| Revenue (TTM) | $282.38B |
| Gross Profit (TTM) | $25.80B |
| EBITDA | $12.76B |
| Operating Margin | 3.99% |
| Return on Equity | 16.80% |
| Return on Assets | 4.46% |
| Revenue/Share (TTM) | $1069.94 |
| Book Value | $161.62 |
| Price-to-Book | 1.75 |
| Price-to-Sales (TTM) | 0.26 |
| EV/Revenue | 0.353 |
| EV/EBITDA | 7.77 |
| Quarterly Earnings Growth (YoY) | 10.20% |
| Quarterly Revenue Growth (YoY) | 6.70% |
| Shares Outstanding | $264.24M |
| Float | $262.95M |
| % Insiders | 1.44% |
| % Institutions | 92.54% |
Volatility is currently contracting
Cigna Group remains a "Buy," with double-digit adjusted EPS growth intact and shares trading 28% below fair value. CI's Accredo and AI-powered Pharmacy Forward platforms are key growth drivers, supporting robust revenue and margin expansion through 2028. The company boasts an A- S&P credit rating, strong free cash flow, and a secure, growing dividend with low payout ratios.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna (CI) maintains a Buy rating as valuation remains deeply discounted despite steady earnings growth and raised guidance. CI lifted 2026 adjusted EPS guidance to at least $30.45, targeting 10% EPS growth and mid-single-digit revenue growth through 2027. Capital returns continue with $6.3 billion in cash, ongoing buybacks, and a $1.56 per share dividend, supported by strong operating cash flow.
Cigna Group NYSE: CI raised its full-year 2026 adjusted earnings outlook after reporting second-quarter results that management said exceeded expectations in both its Evernorth health services business and Cigna Healthcare insurance segment.
Cigna delivers an earnings and revenue beat as Cigna Healthcare fuels growth, while the company raises its 2026 EPS outlook despite higher pharmacy costs.
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Cigna Group (CI) Q2 2026 Earnings Call Transcript
Cigna (CI) came out with quarterly earnings of $7.78 per share, beating the Zacks Consensus Estimate of $7.58 per share. This compares to earnings of $7.2 per share a year ago.
The Cigna Group Thursday reported second quarter net income of nearly $1.7 billion despite continued elevated medical costs dogging the entire health insurance industry.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CI and any ticker you trade — then tracks every position and per-strategy win rate.
